3Derm Systems, Inc.

Boston, MA · Founded 2012 · Medtech · Acquired

Automated diagnostic and triage system for skin infections and dermatological conditions using imaging and analysis

Claim this profile

Follows are private to you and power your alerts

Updated · 3derm.com

Sector
Medtech
Headquarters
Boston, MA
Founded
2012
Latest Form D
$500K, Jul 2019
Total capital
$3.2M
Federal grants
$375K
2 awards · 2018–2019
Rank in peer group#10 of 11
Private capital raised
$2.8M
3 Form D · last Jul 2019
87 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
1 pending

Capital timeline

201420152016201720182019FEDERAL ↑EQUITY ↓Cumulative $3.2M$150K$225K1st Form D$675K2nd Form D$1.7M3rd Form D$500K
201420152016201720182019FEDERAL ↑EQUITY ↓Cumulative $3.2M$150K$225K2nd Form D$1.7M3rd Form D$500K

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$500K
  • Federal grantNSF · Phase I · STTR Phase I: Intelligent Scoring of Inflammatory Skin Disease Progression$225K
  • Federal grantDefense · Phase I · Clinical Decision Support for Dermatology Diagnosis in No-Communications Theater Environments$150K
  • Private capital raisedForm D · SEC · 2nd filing$1.7M
  • Private capital raisedForm D · SEC · 1st filing$675K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 11 peers

Line = median

Medtech · System

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Anthony CriscuoloDirectorNamed in SEC Form D filings
  • Christopher FordDirectorNamed in SEC Form D filings
  • Elizabeth AsaiExecutive Officer, DirectorNamed in SEC Form D filings
  • Elliot SwartExecutive Officer, DirectorNamed in SEC Form D filings
  • Gina VillaniDirectorNamed in SEC Form D filings
  • Roy MillerDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 1
  • PendingDiagnosing Skin Conditions Using Machine-learned ModelsUSPTOApplication PCTUS2020040270
  • PhasiQ, Inc.Similar federal contract value in Medtech · null in contracts
  • Infecho Scientific LLCSimilar federal contract value in Medtech · null in contracts
  • Puratec LLCSimilar federal contract value in Medtech · null in contracts
  • PIEZO THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
  • Neurodyne, Inc.Similar federal contract value in Medtech · null in contracts
  • RELAVO, INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .